Australia Launches National Biobank to Tackle Bone Marrow Failure Syndromes
Highlights
Nationwide Collaboration: Monash University and Maddie Riewoldt’s Vision spearhead a critical research platform for Bone Marrow Failure Syndromes (BMFS).
Integrated Infrastructure: The biobank...
CureDuchenne Launches Duchenne Muscular Dystrophy Biobank
CureDuchenne, a global leader in research, patient care, and
innovation in improving and extending the lives of those living with Duchenne
muscular dystrophy (Duchenne), has initiated...
Air Liquide Healthcare Brings Together it’s Four Biobanks Under the Name BioKryo in Germany
With a storage capacity of more than 20 million biological samples (tissues, cells ad DNA), the BioKryo network operates in three European countries, with...
Philippines to Launch First Coral Larvae Cryobank to Boost Reef Restoration
First in the Country: UP MSI to set up the Philippines’ first coral larvae cryobank at Bolinao Marine Laboratory.
Regional Collaboration: Partnership with...
A Living Biobank Of Non-Small Cell Lung Cancer Organoids
Globally, cancer of the lung is the most common cause of
cancer related mortality. It is also the most commonly diagnosed. 3D patient derived
organoids provide...
Germany’s Ulm University Hospital Launches Pediatric Biobank to Advance Childhood Disease Research
Pediatric Biobank Established: Ulm University Hospital expands its pediatric research infrastructure with a new decentralized biobank.
Integrated Biobank Network: KJBU biobank to connect...
Down Syndrome Research Biobank Launched via a Collaboration between Cincinnati Children’s and DownSyndrome Achieves
Cincinnati Children's Hospital Medical Center has collaborated with DownSyndrome Achieves (DSA) to launch a research biobank, which serves as a central repository for biospecimens...
Biodiversity Biobanks South Africa (BBSA): A Central Repository Launches to Conserve and Manage Biodiversity...
In a first for the country, a central repository, Biodiversity Biobanks South Africa (BBSA), was launched to conserve and manage biodiversity samples on 1 March...
The Swedish p53 Study (SWEP53) With Biobank Option
The Swedish p53 Study (SWEP53) is a germ line TP53 pathogenic variant patient registry with three optional parts: a biobank, a surveillance program and...
A Living Biobank Of Ovarian Cancer – A Model For Drug Discovery
Synthetic lethality is a circumstance in which a drug is selectively
deadly to cancer cells due to the mutations and genetic changes that have
occurred during...



















